NCT06539169 - FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

June 10, 2026

Study Completion Date

June 10, 2026

Conditions

Alpha-ThalassemiaBeta-ThalassemiaAmyloidosisAmyotrophic Lateral SclerosisCreutzfeld-Jakob DiseaseCystic FibrosisDuchenne Muscular DystrophyEarly-Onset Alzheimer DiseaseEhlers-Danlos SyndromeHuntington DiseaseGaucher DiseaseGM1 GangliosidosisMyasthenia GravisPompe DiseaseSickle Cell DiseaseTransthyretin Amyloid CardiomyopathyRare Diseases

Trial Locations (1)

94022

RECRUITING

xCures, Los Altos